Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotection

American Journal of Therapeutics

Volumn 6, Issue 4, 1999, Pages 191-197

  Sharma, Sangeeta ^a   Rastogi, S ^b   Gupta, V ^b   Rohtagi, D ^c   Gulati, P ^d  

^a INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Panacea Biotec Ltd   (India)

^d MR Centre   (India)

Author keywords

Chondroprotection; Efficacy; Magnetic resonance imaging; Nimesulide; Osteoarthritis; Piroxicam; Safety

Indexed keywords

NIMESULIDE; PARACETAMOL; PIROXICAM; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HUMAN; JOINT FUNCTION; KNEE; KNEE OSTEOARTHRITIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH;

EID: 0032776282     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199907000-00003     Document Type: Article

References (15)

1. Frolich JC: A classification of non steroidal anti-inflammatory drugs according to relative inhibition of cyclo-oxygenase isoenzyme. Tips 1997;18:30-34.
2. Ghosh P: Nonsteroidal anti-inflammatory drugs and chondroprotection. Drugs 1993;46:834-846.
3. Glukert K, Blank-Schal A, Hofmann G, et al: Possibilities for early detection of osteoarthritis with imaging procedures. Orthopade 1990;19:50-57.
4. Braunstein EM, Brandt KD, Albrecht M: MRI demonstration of hypertrophic articular cartilage repair in osteoarthritis. Skeletal Radiol 1990;19:335-359.
5. Steinbrocker O, Traeger CH, Batterman C: Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-662.
6. Lequesne MG, Mery C, Samson M, Gerard P: Indexes of severity of osteoarthritis of the hip and knee. Scand J Rheumatol 1987;65(suppl):85-89.
7. Mann HB, Whitney DR: On a test of whether one of the two random variables is stochastically larger than the other. Ann Math Statist 1947;18:50-60.
8. Dreiser RL, Riebenfeld D: Nimesulide in treatment of osteoarthritis: double-blind studies in comparison with piroxicam, ketoprofen and placebo. Drugs 1993;46(suppl 1):191-195.
9. Pochobradsky MG, Mele G, Beretta A: Post-marketing survey of nimesulide in the short-term treatment of osteoarthritis. Drugs Exp Clin Res 1991;17:197-204.
10. Mele G, Memeo A, Mellesi L, Gatti F: Post-marketing surveillance on nimesulide in the treatment of 8,354 patients over 60 years old affected with acute and chronic musculo-skeletal diseases. Arch Med Intern 1992;42:213-221.
11. Herman JH, Appel AM, Hess EV: Modulation of cartilage destruction by select nonsteroidal anti-inflammatory drugs: in vitro effect on the synthesis and activity of catabolism inducing cytokines produced by osteoarthritic and rheumatoid synovial tissue. Arthritis Rheum 1987;30:257-265.
12. Vignon E, Mathien P, Louisot P, Richard M: In vitro effect of non steroidal anti-inflammatory drugs on proteoglynase and collagenase activity in human osteoarthritic cartilage. Arthritis Rheum 1991;34:1332-1335.
13. Pelletier JP, Pelletier JM: Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of osteoarthritic cartilage. Drugs 1993;46(suppl 1): 34-39.
14. Dallegri F, Otonello L, Dapino P, Bevilacqua M: The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration 1992;59:1-4.
15. Otonello L, Dapino P, Dallegri F: Inactivation of alpha-1-proteinase inhibitor by neutrophil metallproteinases -crucial role of myeloperoxidase system and effects of anti-inflammatory drug nimesulide. Respiration 1993; 60:32-7.